Научная литература
booksshare.net -> Добавить материал -> Медицина -> Насонов Е.Л. -> "Антифосфолипидный синдром" -> 155

Антифосфолипидный синдром - Насонов Е.Л.

Насонов Е.Л. Антифосфолипидный синдром — М.: Литтерра, 2004. — 440 c.
ISBN 5-98216-010-5
Скачать (прямая ссылка): antisindrom2004.pdf
Предыдущая << 1 .. 149 150 151 152 153 154 < 155 > 156 157 158 159 160 161 .. 184 >> Следующая

85. Coul BM, Williams LS, Goldstein LB, et al. Anticoagulants and antiplatelet agents in acute ischemic stroke. Report of the joint stroke guideline development committee of the American Academy of Neurology and the American Stroke Association (a Division of the Americam Heart Associations). Stroke 2002; 33: 1934—1942.
86. Asherson RA, Espinosa G, Cervera R, Font J, Reverter JC. Catastrophic antiphospholipid syndromr; proposed guidelines for diagnosis and treatment. J Clin Rheumatol 2002; 8: 157—165.
87. Aherson RA, Cervera R, de Groot P, Erkan D, et al. Catastrophic antiphospholipid syndrome (CAPS): International consensus statement on classifacation criteria and treatment guidelanes. Lupus 2003; 12: 530—544.
88. Erkan D, Cervra R, Asherson RA. Catastrophic antiphospholipid syndrome; where do we stand. Arthritis Rheum 2003; 48: 3320—327.
89. Belmont HM, Abramson SB, Lie jt. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus: interaction of inflammatory cells and activated endothelium. Arthritis Rheum 1996; 39: 9—22.
90. Lockwood CJ, Schur PH. Monitoring and treatment of pregnant women with the antiphos-pholipid syndrome. UpToDate 2003; 11.2.
91. Sammaritano L. Update on the management of the pregnant patients with antiphospho-lipid antibody. Curr Rheumatol Report 2001; 3: 213—221.
92. Derksen RHWM, de Groot Ph G, Nieuwen-huis HK, Christiaens GCML. How to treat women with antiphospholipid antibodies in pregnancy? Ann Rheum Dis 2001; 60: 1.
93. Branch WD, Silver RM, Blackwell JL, et al. Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience. Obstet Gynecol 1992; 80: 614.
94. Tincani A, Branch W, Levy RA, et al. Treatment ofpregnant patients with antiphospho-lipid syndrome. Lupus 2003; 12: 524—529.
95. Ermel, LD, Marshburn, PB, Kutteh, WH. Interaction of heparin with antiphospholipid antibodies (APA) from the sera of women with recurrent pregnancy loss (RPL). Am J Reprod Immunol 1995; 33:14.
96. Girardi G, Berman J, Tudoran R, et al. A potential mechanism for therapeutic efficacy for
SHS-OOO4.qxd 21.11.2006 16:56 Page 376
Насонов Е.Л. Антифосфолипидный синдром.
heparin in antiphospholipid-induced pregnancy loss inhibition of complement. ACR/ARHP Annual Scientific Meeting, Orlando, October 24—28, 2003; 324 (abst).
97. Triolo G, Ferrante A, Ciccia F, Accardo-Palumbo A, Perino A, Castelli A, et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immuno-globulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum 2003; 48: 728—731.
98. Erkan D. The relation between antiphos-pholipid syndrome-related pregnancy morbidity and non-gravid vascular thrombosis: a review of the literature and management strategies. Curr Rheumatol Rep 2002; 4: 379.
99. Dahlman TC. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993; 168: 1265.
100. Ruiz-Irastorza G, Khamashta MA, Nel-son-Piercy C, Hughes GRV. Lupus pregnancy: is heparin a risk factor for osteoporosis. Lupus 2001; 10: 597—600.
101. American College of Obstetricians and Gynecologists. Anticoagulation with low-molecular-weight heparin during pregnancy. ACOG committee opinion 211. ACOG 1998; Washington, DC.
102. Pauzner R, Dulitzki M, Langevitz P, et al. Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy. Thromb Haemost 2001; 86: 1379.
103. Udoff LC, Branch DW. Management of patients with antiphospholipid antibodies undergoing in vitro fertilization. J Autoimmun 2000; 15: 209.
104. Cowchock S. Prevention of fetal death in the antiphospholipid antibody syndrome. Lupus 1996; 5: 467.
105. Lockshin MD. Answers to the antiphos-pholipid-antibody syndrome? (editorial). NEngl J Med 1995; 332:1025.
106. Rosove MH, Tabsh K, Wasserstrum N, et al. Heparin therapy for pregnant women with lupus anticoagulant and anticardiolipin antibodies. Obstet Gynecol 1990; 75: 630.
107. Cowchock FS, Reece EA, Balaban D, et al. Repeated fetal losses associated with antiphos-pholipid antibodies: A collaborative randomized trial comparing prednisone to low-dose heparin. Am J Obstet Gynecol 1992; 166:1318.
108. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314: 253.
109. Valensise H, Vaquero E, De Carolis C, Stipa E, et al. Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin (IVIG). Prenat Diagn 1995; 15: 509.
110. Branch DW, Peaceman AM, Druzin M, et al. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. Am J Obstet Gynecol 2000; 182:122.
Предыдущая << 1 .. 149 150 151 152 153 154 < 155 > 156 157 158 159 160 161 .. 184 >> Следующая

Реклама

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

Есть, чем поделиться? Отправьте
материал
нам
Авторские права © 2009 BooksShare.
Все права защищены.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed